LEFLUNOMIDE APOTEX leflunomide 20mg tablets blister pack

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

leflunomide, Quantity: 20 mg

Pieejams no:

Arrotex Pharmaceuticals Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

Leflunomide

Zāļu forma:

Tablet, uncoated

Kompozīcija:

Excipient Ingredients: crospovidone; magnesium stearate; colloidal anhydrous silica; lactose

Ievadīšanas:

Oral

Vienības iepakojumā:

30 tablets

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

LEFLUNOMIDE APOTEX is indicated for the treatment of: active rheumatoid arthritis; active psoriatic arthritis. GenRx Leflunomide is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease. The combined use of GenRx Leflunomide with other disease modifying antirheumatic drugs (DMARDs) has not been adequately studied (see Precautions).

Produktu pārskats:

Visual Identification: White, arc-triangular shaped tablet. Engraved "LE" over "20" on one side and "APO" on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Autorizācija statuss:

Registered

Autorizācija datums:

2008-07-14